Monopar Therapeutics

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Monopar Therapeutics
CIK #0001645469
EDGAR Form CIK 2011 - 2026
10-K [0001645469]
10-Q [0001645469]
3 [0001645469]
4 [0001645469]
8-K [0001645469]
D [0001645469]
SC 13D [0001645469]
SC 13G [0001645469]
Form 13D/13G Filer Form 13D/13G Subject Filed
Saturn V Capital Management LP Monopar Therapeutics [2026-05-15]
Adage Capital Management LP Monopar Therapeutics [2025-02-12]
Janus Henderson Group PLC Monopar Therapeutics [2024-11-06]
RA Capital Management LP Monopar Therapeutics [2024-10-31]
Astrazeneca PLC Monopar Therapeutics [2024-10-28]
Tang Capital Management LLC Monopar Therapeutics [2024-10-24]
Klunzinger Jeffrey R Monopar Therapeutics [2023-06-02]
Monopar Therapeutics Gem Pharmaceuticals LLC [2019-12-23]
Monopar Therapeutics Tactic Pharma LLC [2019-12-23]
Form 3/4/5 Subject 2011 - 2026
Robinson Chandler
Monopar Therapeutics
Vu Quan Anh
Cittadine Andrew
Sweeny Nicole
Rodriguez Susan
Rioux Patrice
Klausner Arthur J
Hendricks Diane
Talukdar Lavina
Anderson Raymond
Starr Christopher M
Tsuchimoto Kim R
Mazar Andrew Paul
O'Halloran Thomas V
Brown Michael J
Tactic Pharma LLC
TacticGem LLC
Radhakrishnan Karthik
Filho Jose Octavio Pinto Costa
Leo Karl
Gem Pharmaceuticals LLC
Pharma Investments LLC
Anderson Kirsten
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Monopar Therapeutics MNPR
Stock Options · derivative
2026-03-02 Grant 48,728 $0.00
Monopar Therapeutics MNPR
Stock Option · derivative
2026-01-01 Grant 2,000 $0.00
Monopar Therapeutics MNPR
Restricted Stock Unit · derivative
2025-12-31 Option exercise 4,326 $0.00
Monopar Therapeutics MNPR
Common Stock
2025-12-31 Option exercise 8,724
Monopar Therapeutics MNPR
Common Stock
2025-12-31 Option exercise 4,326
Monopar Therapeutics MNPR
Common Stock
2025-12-31 Tax withheld 1,889 $65.30 123,352
Monopar Therapeutics MNPR
Common Stock
2025-12-31 Tax withheld 2,558 $65.30 167,037
Monopar Therapeutics MNPR
Restricted Stock Unit · derivative
2025-12-31 Option exercise 8,724 $0.00
Monopar Therapeutics MNPR
Common Stock
2025-12-26 Buy 1,500 $69.95 104,925
Monopar Therapeutics MNPR
Common Stock
2025-12-18 Sell 4,660 $67.06 312,500
Monopar Therapeutics MNPR
Common Stock
2025-12-18 Sell 461 $68.09 31,389
Monopar Therapeutics MNPR
Common Stock
2025-12-16 Other 43,499 $0.00
Monopar Therapeutics MNPR
Common Stock
2025-12-16 Other 7,710 $0.00
Monopar Therapeutics MNPR
Restricted Stock Units · derivative
2025-12-02 Grant 9,826 $0.00
Monopar Therapeutics MNPR
Restricted Stock Units · derivative
2025-12-02 Grant 49,133 $0.00
Monopar Therapeutics MNPR
Stock Options · derivative
2025-12-02 Grant 7,135 $0.00
Monopar Therapeutics MNPR
Stock Options · derivative
2025-12-02 Grant 2,924 $0.00
Monopar Therapeutics MNPR
Stock Options · derivative
2025-12-02 Grant 2,924 $0.00
Monopar Therapeutics MNPR
Restricted Stock Units · derivative
2025-12-02 Grant 13,919 $0.00
Monopar Therapeutics MNPR
Stock Options · derivative
2025-12-02 Grant 2,924 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com